ethris

ethris GmbH is a technical innovator in the emerging field of messenger RNA therapeutics.

ethris develops transcript therapeutics with a focus on regenerative medicine. ethris GmbH possesses an enabling platform for Transcript Therapies. SNIMRNAis a first-in-class biopharmaceutical which provide a compelling alternative for recombinant protein or gene therapies. SNIMRNAs encode therapeutic proteins to be produced in the patient‘s body and overcome short duration effects of recombinant proteins. SNIMRNA Transcript Therapy is a new option for a broad variety of diseases, either acquired or genetically predetermined, life style- or age-related, rare or frequent.